Use of genetically encoded, light-gated ion translocators to control tumorigenesis
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
// Brook T. Chernet 1 , Dany S. Adams 1 , Maria Lobikin 1 , Michael Levin 1 1 Center for Regenerative and Developmental Biology and Department of Biology Tufts University, Medford, MA 02155, USA Correspondence to: Michael Levin, e-mail: michael.levin@tufts.edu Keywords: V mem , bioelectricity, voltage, RAS, optogenetics Received: November 22, 2015 Accepted: February 11, 2016 Published: March 16, 2016 ABSTRACT It has long been known that the resting potential of tumor cells is depolarized relative to their normal counterparts. More recent work has provided evidence that resting potential is not just a readout of cell state: it regulates cell behavior as well. Thus, the ability to control resting potential in vivo would provide a powerful new tool for the study and treatment of tumors, a tool capable of revealing living-state physiological information impossible to obtain using molecular tools applied to isolated cell components. Here we describe the first use of optogenetics to manipulate ion-flux mediated regulation of membrane potential specifically to prevent and cause regression of oncogene-induced tumors. Injection of mutant-KRAS mRNA induces tumor-like structures with many documented similarities to tumors, in Xenopus tadpoles. We show that expression and activation of either ChR2 D156A , a blue-light activated cation channel, or Arch , a green-light activated proton pump, both of which hyperpolarize cells, significantly lowers the incidence of KRAS tumor formation. Excitingly, we also demonstrate that activation of co-expressed light-activated ion translocators after tumor formation significantly increases the frequency with which the tumors regress in a process called normalization. These data demonstrate an optogenetic approach to dissect the biophysics of cancer. Moreover, they provide proof-of-principle for a novel class of interventions, directed at regulating cell state by targeting physiological regulators that can over-ride the presence of mutations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The development and application of optogenetics
Fenno, L., Yizhar, O., & Deisseroth, K. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113817 · Cited by 1,822 · cited 1×
“It has primarily been used as a precise tool to control neural and muscle excitation/inhibition, and to regulate biochemical processes [44, 45].”
MethodMembrane potential and cancer progression
Yang, M., & Brackenbury, W. J. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00185 · Cited by 614
Bioelectric controls of cell proliferation: Ion channels, membrane voltage and the cell cycle
Blackiston, D. J., McLaughlin, K. A., & Levin, M. (2009) · Cell Cycle · doi:10.4161/cc.8.21.9888 · Cited by 468
Self-citationLiGluR restores visual responses in rodent models of inherited blindness
Caporale, N., Kolstad, K. D., Lee, T., Tochitsky, I., Dalkara, D., Trauner, D., Kramer, R., Dan, Y., Isacoff, E. Y., & Flannery, J. G. (2011) · Molecular Therapy · doi:10.1038/mt.2011.103 · Cited by 182
Lobikin, M., Chernet, B., Lobo, D., & Levin, M. (2012) · Physical Biology · doi:10.1088/1478-3975/9/6/065002 · Cited by 166 · cited 2×
“Moreover, this model system offers well characterized tumor-inducing molecular reagents (the human oncogenes Gli1, Xrel3, p53Trp248 and KRASG12D), whose expression results in induced tumor-like structures (ITLSs) with many of the hallmarks of mammalian tumors: increased mitotic activity, induced vasculogenesis, increa…”
BackgroundAdams, D. S., & Levin, M. (2012) · Cold Spring Harbor Protocols · doi:10.1101/pdb.top067710 · Cited by 88
Self-citation
Cited by
Bioelectric signaling: Reprogrammable circuits underlying embryogenesis, regeneration, and cancer
Levin, M. (2021) · Cell · doi:10.1016/j.cell.2021.02.034 · Cited by 505
Self-citationLevin, M. (2019) · Frontiers in Psychology · doi:10.3389/fpsyg.2019.02688 · Cited by 297
Self-citationLevin, M., Pezzulo, G., & Finkelstein, J. M. (2017) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071114-040647 · Cited by 287
Self-citationLevin, M. (2022) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2022.768201 · Cited by 195
“This process can be prevented (Chernet and Levin, 2013a,b; Chernet et al., 2016) by artificially regulating their bioelectric state [e.”
BackgroundSelf-citationCollective intelligence: a unifying concept for integrating biology across scales and substrates
McMillen, P., & Levin, M. (2024) · Communications Biology · doi:10.1038/s42003-024-06037-4 · Cited by 122
Self-citation
Metadata
- Authors
- Chernet, B. T., Adams, D. S., Lobikin, M., & Levin, M.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2016-03-16
- Volume
- 7
- Issue
- 15
- Pages
- 19575-19588
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2299444549
- Cited by
- 101
- References
- 6
- FWCI
- 6.19
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Use of genetically encoded, light-gated ion translocators to control tumorigenesis. https://app.cochat.ai/papers/10.18632/oncotarget.8036
- The paper
- Chernet, B. T., Adams, D. S., Lobikin, M., & Levin, M. (2016). Use of genetically encoded, light-gated ion translocators to control tumorigenesis. Oncotarget. https://doi.org/10.18632/oncotarget.8036
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.